The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Dopamine transporter density in the basal ganglia assessed with [123I]IPT SPET in children with attention deficit hyperactivity disorder
Open accessAbstract
Attention deficit hyperactivity disorder (ADHD) is a psychiatric disorder in childhood that is known to be associated with dopamine dysregulation. In this study, we investigated dopamine transporter (DAT) density in children with ADHD using iodine-123 labelled N-(3-iodopropen-2-yl)-2β-carbomethoxy-3β-(4-chlorophenyl) tropane ([123I]IPT) single-photon emission tomography (SPET) and postulated that an alteration in DAT density in the basal ganglia is responsible for dopaminergic dysfunction in children with ADHD. Nine drug-naive children with ADHD and six normal children were included in the study. We performed brain SPET 2 h after the intravenous administration of [123I]IPT and carried out both quantitative and qualitative analyses using the obtained SPET data, which were reconstructed for the assessment of the specific/non-specific DAT binding ratio in the basal ganglia. We then investigated the correlation between the severity scores of ADHD symptoms in children with ADHD assessed with ADHD rating scale-IV and the specific/non-specific DAT binding ratio in the basal ganglia. Drug-naive children with ADHD showed a significantly increased specific/non-specific DAT binding ratio in the basal ganglia compared with normal children. However, no significant correlation was found between the severity scores of ADHD symptoms in children with ADHD and the specific/non-specific DAT binding ratio in the basal ganglia. Our findings support the complex dysregulation of the dopaminergic neurotransmitter system in children with ADHD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mannuzza, S. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820190067007 · Cited by 1,368
Vaidya, C. J., Austin, G., Kirkorian, G., Ridlehuber, H. W., Desmond, J. E., Glover, G. H., & Gabrieli, J. D. E. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.24.14494 · Cited by 845
Dopamine transporter density in patients with attention deficit hyperactivity disorder
Dougherty, D. D., Bonab, A. A., Spencer, T. J., Rauch, S. L., Madras, B. K., & Fischman, A. J. (1999) · The Lancet · doi:10.1016/s0140-6736(99)04030-1 · Cited by 684
Gill, M., Daly, G., Heron, S., Hawi, Z., & Fitzgerald, M. (1997) · Molecular Psychiatry · doi:10.1038/sj.mp.4000290 · Cited by 482
Dresel, S., Krause, J., Krause, K.-H., LaFougere, C., Brinkbäumer, K., Kung, H. F., Hahn, K., & Tatsch, K. (2000) · European Journal of Nuclear Medicine · doi:10.1007/s002590000330 · Cited by 278
High Midbrain [ 18 F]DOPA Accumulation in Children With Attention Deficit Hyperactivity Disorder
Ernst, M., Zametkin, A. J., Matochik, J. A., Pascualvaca, D., Jons, P. H., & Cohen, R. M. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.8.1209 · Cited by 256
Cited by
Attention-deficit hyperactivity disorder
Biederman, J., & Faraone, S. V. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66915-2 · Cited by 1,463
Insights into the neural basis of response inhibition from cognitive and clinical neuroscience
Chambers, C. D., Garavan, H., & Bellgrove, M. A. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2008.08.016 · Cited by 938
del Campo, N., Chamberlain, S. R., Sahakian, B. J., & Robbins, T. W. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.02.036 · Cited by 685
Frodl, T., & Skokauskas, N. (2012) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2011.01786.x · Cited by 530
The Dopamine Transporter and Attention-Deficit/Hyperactivity Disorder
Madras, B. K., Miller, G. M., & Fischman, A. J. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.10.011 · Cited by 393
Spencer, T., Biederman, J., Wilens, T., Doyle, R., Surman, C., Prince, J., Mick, E., Aleardi, M., Herzig, K., & Faraone, S. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.11.043 · Cited by 385
Wilens, T. E. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318173312f · Cited by 269
Nutt, D. J., Fone, K., Asherson, P., Bramble, D., Hill, P., Matthews, K., Morris, K. A., Santosh, P., Sonuga-Barke, E., Taylor, E., et al. (2007) · Journal of Psychopharmacology · doi:10.1177/0269881106073219 · Cited by 259
“In addition, there is evidence from two out of four studies that the DAT1 risk genotype for ADHD is associated with increased striatal DAT binding (Heinz et al., 2000; Jacobsen et al., 2000; Martinez et al., 2001; Cheon et al., 2003).”
BackgroundPhthalates Exposure and Attention-Deficit/Hyperactivity Disorder in School-Age Children
Kim, B.-N., Cho, S.-C., Kim, Y., Shin, M.-S., Yoo, H.-J., Kim, J.-W., Yang, Y. H., Kim, H.-W., Bhang, S.-Y., & Hong, Y.-C. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.07.034 · Cited by 252
Self-citationBrain dopamine transporter levels in treatment and drug naive adults with ADHD
Volkow, N. D., Wang, G.-J., Newcorn, J., Fowler, J. S., Telang, F., Solanto, M. V., Logan, J., Wong, C., Ma, Y., Swanson, J. M., et al. (2007) · NeuroImage · doi:10.1016/j.neuroimage.2006.10.014 · Cited by 249
“Moreover, subsequent replications by the groups that initially reported DAT elevations reveal either smaller differences or subgroups with no changes or even DAT decreases (summarized Table 3) (Krause et al., 2000, 2002; Staley et al., 2001; Larisch et al., 2006; Cheon et al., 2003, 2005).”
BackgroundJucaite, A., Fernell, E., Halldin, C., Forssberg, H., & Farde, L. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.11.009 · Cited by 236
Bellgrove, M. A., Hawi, Z., Kirley, A., Gill, M., & Robertson, I. H. (2005) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2005.03.011 · Cited by 218
ADHD and the Prefrontal Cortex
Arnsten, A. F. T. (2009) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2009.01.018 · Cited by 220
Spencer, T. J., Biederman, J., Madras, B. K., Dougherty, D. D., Bonab, A. A., Livni, E., Meltzer, P. C., Martin, J., Rauch, S., & Fischman, A. J. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.12.008 · Cited by 150
SPECT and PET of the dopamine transporter in attention-deficit/hyperactivity disorder
Krause, J. (2008) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.8.4.611 · Cited by 110
Brain function and structure in adults with attention-deficit/hyperactivity disorder
Seidman, L. J., Valera, E. M., & Bush, G. (2004) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2004.01.002 · Cited by 106
Sobel, L. J., Bansal, R., Maia, T. V., Sanchez, J., Mazzone, L., Durkin, K., Liu, J., Hao, X., Ivanov, I., Miller, A., et al. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.09091259 · Cited by 105
Giacobini, M., Medin, E., Ahnemark, E., Russo, L. J., & Carlqvist, P. (2018) · Journal of Attention Disorders · doi:10.1177/1087054714554617 · Cited by 94
“ADHD is thought to have a biological basis (Cheon et al., 2003; Pliszka, 2005), but all definitions of ADHD are still based on behavioral descriptions and observations (National Collaborating Centre for Mental Health, 2009).”
BackgroundAdvancing the spontaneous hypertensive rat model of attention deficit/hyperactivity disorder.
Kantak, K. M., Singh, T., Kerstetter, K. A., Dembro, K. A., Mutebi, M. M., Harvey, R. C., Deschepper, C. F., & Dwoskin, L. P. (2008) · Behavioral Neuroscience · doi:10.1037/0735-7044.122.2.340 · Cited by 95
Comorbidity of ADHD and Substance Use Disorder (SUD): A Neuroimaging Perspective
Frodl, T. (2010) · Journal of Attention Disorders · doi:10.1177/1087054710365054 · Cited by 87
Krause, J., la Fougere, C., Krause, K.-H., Ackenheil, M., & Dresel, S. H. (2005) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-005-0602-x · Cited by 84
Johnson, K. A., Barry, E., Bellgrove, M. A., Cox, M., Kelly, S. P., Dáibhis, A., Daly, M., Keavey, M., Watchorn, A., Fitzgerald, M., et al. (2008) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2008.01.002 · Cited by 62
Larisch, R., Sitte, W., Antke, C., Nikolaus, S., Franz, M., Tress, W., & M??ller, H.-W. (2006) · Nuclear Medicine Communications · doi:10.1097/00006231-200603000-00010 · Cited by 58
la Fougère, C., Krause, J., Krause, K.-H., Josef Gildehaus, F., Hacker, M., Koch, W., Hahn, K., Tatsch, K., & Dresel, S. (2006) · Nuclear Medicine Communications · doi:10.1097/01.mnm.0000230077.48480.68 · Cited by 57
Immunologic and neurodevelopmental susceptibilities of autism
Pessah, I. N., Seegal, R. F., Lein, P. J., LaSalle, J., Yee, B. K., Van De Water, J., & Berman, R. F. (2008) · NeuroToxicology · doi:10.1016/j.neuro.2008.02.006 · Cited by 51
Kollins, S. H., English, J., Robinson, R., Hallyburton, M., & Chrisman, A. K. (2009) · Psychopharmacology · doi:10.1007/s00213-008-1439-6 · Cited by 48
“…is supported by studies showing differences in dopamine transporter (DAT) density in relevant striatal areas in ADHD patients compared to controls (Cheon et al. 2003; Dougherty et al. 1999; Dresel et al. 2000; Krause et al. 2000, 2002, 2003; Larisch et al. 2006; Spencer et al. 2005; Volkow et al.…”
Contini, V., Victor, M. M., Marques, F. Z. C., Bertuzzi, G. P., Salgado, C. A. I., Silva, K. L., Sousa, N. O., Grevet, E. H., Belmonte-de-Abreu, P., & Bau, C. H. D. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-009-0362-2 · Cited by 27
“There is evidence that patients with ADHD show an elevated striatal DAT activity, compared to controls (Dougherty et al. 1999; Krause et al. 2000; Dresel et al. 2000; Cheon et al. 2003 ).”
Backgroundda Silva, N., Szobot, C. M., Anselmi, C. E., Jackowski, A. P., Chi, S. M., Hoexter, M. Q., Anselmi, O. E., Pechansky, F., Bressan, R. A., & Rohde, L. A. (2011) · Clinical Nuclear Medicine · doi:10.1097/rlu.0b013e318219b49d · Cited by 21
Metadata
- Authors
- Cheon, K.-A., Ryu, Y. H., Kim, Y.-K., Namkoong, K., Kim, C.-H., & Lee, J.
- Venue
- European Journal of Nuclear Medicine and Molecular Imaging
- Published
- 2003-02
- Volume
- 30
- Issue
- 2
- Pages
- 306-311
- ISSN
- 1619-7070 (ISSN-L)
- 1619-7089
- OpenAlex
- W1997395040
- Cited by
- 187
- References
- 6
- FWCI
- 9.34
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.